66results about How to "Multiple consumption options" patented technology

The invention provides a folic acid pellet preparation composed of folic acid and medical supplementary materials. The folic acid pellet preparation is characterized in that the medical supplementary materials are excipients and binders; and in the pellet preparation, the content of folic acid is 0.02-20 percent by weight, the content of excipients is 75-99.98 percent by weight, and the content of binders is 1-5 percent by weight. The pellet preparation has high dissolution rate and high bioavailability, and the preparation method is simple, convenient and easy for operation.

The invention provides a tea polyphenols micro-pill that is prepared from tea polyphenols and pharmaceutical adjuvant, which is characterized in that the pharmaceutical adjuvant is an excipient and a bonding agent. The tea polyphenol micro-pill comprises (by weight percentage) that: tea polyphenols 20-80 percent, the excipient 15-79 percent and the bonding agent 1-5 percent. The tea polyphenols micro-pill can be made into sustained-release preparation or enteric-coated preparation. The pharmacological experiment indicates that the tea polyphenols micro-pill of the invention has good effect on radioresistance, anti-aging, etc.

The invention provides sanchi extract pellets, which are prepared from a sanchi extract and medicinal accessories, and are characterized in that: the medicinal accessories comprise an excipient and a bonding agent; the sanchi extract accounts for 10 to 90 percent of the weight of the pellets; the excipient accounts for 4 to 89 percent of the weight of the pellets; and the bonding agent accounts for 1 to 6 percent of the weight of the pellets. The pellets can be made into a sustained-release or enteric-coated preparation. The sanchi extract pellets of the invention have high dissolution rate and high bioavailability. The method of the invention is simple, convenient and easy to operate.

The invention provides a zinc gluconate pellet preparation, which is prepared from zinc gluconate and pharmaceutic adjuvant, and is characterized in that: the pharmaceutic adjuvant is an excipient and an adhesive, wherein in the pellet preparation, the weight percent of the zinc gluconate is 10 to 80 percent, the weight percent of the excipient is 12 to 89 percent and the weight percent of the adhesive is 1 to 8 percent. The pellet preparation can be prepared into a slow release preparation or an enteric-coated preparation. The zinc gluconate pellet preparation has high dissolution rate, and high bioavailability; and the method is simple, convenient, and easy to operate.

The invention provides a desertliving cistanche herb extract pellet preparation composed of desertliving cistanche herb extract and medical supplementary materials. The desertliving cistanche herb extract pellet preparation is characterized in that the medical supplementary materials are excipients and binders; and in the pellet preparation, the content of desertliving cistanche herb extract 1-80 percent by weight, the content of excipients is 20-99 percent by weight, and the content of binders is 1-5 percent by weight. The pellet preparation has high dissolution rate and high bioavailability, and the preparation method is simple, convenient and easy for operation.

The invention provides a preparation of propolis micropill which is made of propolis and medical accessories and is characterized in that the medical accessories comprise excipient and bond. The preparation of the micropill is made of the following components by the weight percentage: 5-80 percent of propilis, 20-95 percent of excipient and 1-5 percent of bond. The preparation of the micropill has the advantages of high stripping rate and high bioavailability, and the preparation method is simple and convenient and can be operated easily.

The invention provides a chondroitin sulfate pellet preparation, which is prepared from chondroitin sulfate and pharmaceutic adjuvant. The pellet preparation is characterized in that the pharmaceutic adjuvant is excipient and bonding agent, wherein the pellet preparation comprises the following components in percentage by weight: 10 to 90 percent of the chondroitin sulfate, 3 to 89 percent of the excipient, and 1 to 7 percent of the bonding agent. The pellet preparation can be prepared into a slow-release preparation or an enteric-coated preparation as requested. The chondroitin sulfate pellet preparation has high dissolution rate and high bioavailability, and the method is simple and convenient and is easy to operate.

The invention provides an astragalus polyose pellet preparation composed of astragalus polyose and medical supplementary materials. The astragalus polyose pellet preparation is characterized in that the medical supplementary materials are excipients and binders; and in the pellet preparation, the content of astragalus polyose 0.5-70 percent by weight, the content of excipients is 30-99.5 percent by weight, and the content of binders is 1-5 percent by weight. The pellet preparation has high dissolution rate and high bioavailability, and the preparation method is simple, convenient and easy for operation.

The invention provides a beta-carotene micro-pill prepared from beta-carotene and medicinal adjuvant, characterized in that the medicinal adjuvant comprises an excipient and a bonding agent; the content of the beta-carotene in the beta-carotene micro-pill is 1-10 weight percent, the excipient 70-95 weight percent and the bonding agent 1-5 weight percent. The beta-carotene micro-pill of the invention has the advantages of high dissolution rate, high bioavailability, easy preparation method and convenient and easy operation.

The invention provides a red ginseng extract pellet preparation, which is prepared from a red ginseng extract and pharmaceutical adjuvants, and is characterized in that: an excipient and a bonding agent are taken as the pharmaceutical adjuvants; and the pellet preparation comprises the following components in percentage by weight: 2-80 percent of a red ginseng extract, 15-97 percent of an excipient and 1-5 percent of a bonding agent. The pellet preparation can be prepared into a slow-release or enteric preparation as required. As proved by a pharmacological experiment, the pellet has the effects of reinforcing vital energy, restoring pulses, preventing exhaustion, tonifying qi and controlling blood.

The invention provides a sea buckthorn extract pellet preparation composed of sea buckthorn and medical supplementary materials. The sea buckthorn extract pellet preparation is characterized in that the medical supplementary materials are excipients and binders; and in the pellet preparation, the content of sea buckthorn extract 2-75 percent by weight, the content of excipients is 20-97 percent by weight, and the content of binders is 1-5 percent by weight. The pellet preparation has high dissolution rate and high bioavailability, and the preparation method is simple, convenient and easy for operation.

The invention discloses a pellet formulation of donkey-hide gelatin which is prepared by donkey-hide gelatin and pharmaceutical excipients, wherein the pharmaceutical excipients are excipient and adhesive. In the pellet formulation, the weight percentage of the donkey-hide gelatin is 20-80 %, the weight percentage of the excipient is 20-80%, and the weight percentage of the adhesive is 1-5%. The pellet formulation can be made into sustained release formulation or enteric-coated formulation according to the requirements. The inventive pellet formulation has high dissolution rate and bioavailability, easy and convenient preparation method, and easy operation.

The present invention provides a soybean isoflavone pellet preparation which is made from the soybean isoflavone and medical auxiliary materials and is characterized in that the medical auxiliary materials are excipient and bond. In the pellet preparation, the weight percentages of the materials are that: 1 percent to 50 percent of the soybean isoflavone, 55 percent to 98 percent of the excipient and 1 percent to 5 percent of the bond. The pellet preparation can be made into a slow-release or intestinal juice soluble preparation according to the requirement. The pellet preparation of the present invention has high leaching rate and high biological utilization degree, and the preparation method is simple and convenient and is easy for operating.

The invention discloses a pellet formulation of pearl powder which is prepared by pearl powder and pharmaceutical excipients, wherein the pharmaceutical excipients are excipient and adhesive. In the pellet formulation, the weight percentage of the pearl powder is 5-80%, the weight percentage of the excipient is 20-95%, and the weight percentage of the adhesive is 1-5%. The inventive pellet formulation has high dissolution rate and bioavailability, easy and convenient preparation method, and easy operation.

The invention provides a levocarnitine micro-pill which is prepared from levocarnitine and pharmaceutic adjuvant, characterized in that the pharmaceutic adjuvant is an excipient and a bonding agent; the content of the levocarnitine in the levocarnitine micro-pill is 10 to 90 weight percent; the excipient 20-80 weight percent and the bonding agent 1-5 weight percent. The levocarnitine micro-pill of the invention has the advantages of high dissolution rate, high bioavailability, easy preparation method and convenient and easy operation.

The invention discloses a pellet formulation of sea cucumber peptide which is prepared by sea cucumber peptide and pharmaceutical excipients, wherein the pharmaceutical excipients are excipient and adhesive. In the pellet formulation, the weight percentage of the sea cucumber peptide is 2-85%, the weight percentage of the excipient is 20-80%, and the weight percentage of the adhesive is 1-5%. The inventive pellet preparation has high dissolution rate and bioavailability, easy and convenient preparation method, and easy operation.

The invention provides a compound hyaluronic acid pellet preparation. The compound hyaluronic acid pellet preparation is prepared from hyaluronic acid, VC and pharmaceutical accessories and is characterized in that the pharmaceutical accessories include an excipient and an adhesive; and the compound hyaluronic acid pellet preparation contains 5-20% by weight of hyaluronic acid, 1-5% by weight of VC, 70-85% by weight of the excipient and 1-5% by weight of the adhesive. The compound hyaluronic acid pellet preparation disclosed by the invention has high dissolution rate and bioavailability; and a preparation method is simple, convenient and easy to operate.

The invention provides a preparation of a vitamin E micropill which is made of vitamin E and medical accessories and is characterized in that the medical accessories comprise excipient and bond. The preparation of the micropill is made of the following components by the weight percentage: 1-85 percent of vitamin E, 15-99 percent of excipient and 1-5 percent of bond. The preparation of the micropill has the advantages of high stripping rate and high bioavailability, and the preparation method is simple and convenient and can be operated easily.

The invention relates to novel tea polyphenol spherical particles, and provides a tea polyphenol micro-pellet preparation, which is prepared from tea polyphenol and pharmaceutical auxiliary materials, and is characterized in that the pharmaceutical auxiliary materials comprise an excipient and a binder, wherein the tea polyphenol content in the micro-pellet preparation is 5-30 wt%, the excipient content in the micro-pellet preparation is 75-90 wt%, and the binder content in the micro-pellet preparation is 1-5 wt%. According to the present invention, the micro-pellet preparation has characteristics of high bioavailability and high dissolution rate, and the preparation method is simple, convenient and easy to operate.

The invention provides a ganoderan polysaccharide pellet preparation, which is prepared from ganoderan polysaccharides and pharmaceutical adjuvants. The ganoderan polysaccharide pellet preparation is characterized in that: the pharmaceutical adjuvants are an excipient and a binding agent, wherein the pellet preparation comprises the following components in percentage by weight: 10 to 20 percent of ganoderan polysaccharides, 3 to 89 percent of excipient and 1 to 7 percent of bonding agent. The pellet preparation can be prepared into a slow-release or enteric-coated preparation as required. The ganoderan polysaccharide pellet preparation of the invention has high dissolving rate and high bioavailability. The method of the invention is simple, convenient and easy to operate.

The invention provides a compound lucid ganoderma extract pellet preparation. The pellet preparation is prepared from a lucid ganoderma extract, lycopene and pharmaceutical adjuvants and is characterized in that the pharmaceutical adjuvants include an excipient and an adhesive; the weight percentages of the lucid ganoderma extract, lycopene, excipient and adhesive in the pellet preparation are respectively 5-20%, 1-5%, 70-85% and 1-5%. The pellet preparation has high dissolution rate and bioavailability. A preparation method is simple and convenient and is easy to operate.

The invention provides a lutein pellet, which is prepared from lutein and a pharmaceutic adjuvant. The lutein pellet is characterized in that the pharmaceutic adjuvant is an excipient and an adhesive, wherein the pellet preparation contains 5-20% of lutein, 70-85% of excipient and 1-5% of adhesive. The lutein pellet disclosed by the invention is high in dissolution rate, and high in bioavailability, and the preparation method is simple, convenient and easy to operate.

The embodiment of the invention provides a promotion activity publishing method and device. The method comprises the steps of receiving activity configuration data input by a user, storing the activity configuration data into an activity model which comprises an activity information table, an activity rule table, an activity element table and an activity limit table, and generating and publishingpromotion activities according to the stored activity configuration data. According to the method provided by the embodiment of the invention, more promotion activity types can be accommodated, more consumption options are provided for consumers, the consumption experience of the consumers is improved, and the development of telecom operators is facilitated.

The invention provides an aloe extract pellet preparation, which is prepared with aloe extracts and pharmaceutical excipients. The aloe extract pellet preparation is characterized in that the pharmaceutical excipients adopt excipients and adhesives, the weight percentage of the aloe extracts in the pellet preparation is 2-70 percent, the weight percentage of the excipients is 29-90 percent, and the weight percentage of the adhesives is 1-8 percents. The pellet preparation can be made into sustained-release or enteric-coated preparations in accordance with requirements. Pharmacological experiments show that the pellet has good effects of sterilizing, diminishing inflammation, invigorating the stomach, facilitating the bowels, wetting and beautifying.

The invention provides a collagen pellet preparation, which is prepared from a collagen and a pharmaceutic adjuvant. The collagen pellet preparation is characterized in that the pharmaceutic adjuvant is an excipient and an adhesive; the weight percentage of the collagen in the pellet preparation is between 10 and 90 percent; the weight percentage of the excipient is between 20 and 80 percent; and the weight percentage of the adhesive is between 1 and 5 percent. The pellet preparation of the invention has the advantages of high dissolution rate, high bioavailability, simple and convenient preparation method, and easy operation.

The present invention provides a lycopene pellet preparation which is made from the lycopene and medical auxiliary materials and is characterized in that the medical auxiliary materials are excipient and bond. In the pellet preparation, the weight percentages of the materials are: 1 percent to 10 percent of the lycopene, 70 percent to 95 percent of the excipient and 1 percent to 5 percent of the bond. The pellet preparation of the present invention has high leaching rate and high biological utilization degree, and the preparation method is simple and convenient and is easy for operation.

The invention provides a propolis pellet preparation. The pellet preparation is prepared from propolis and pharmaceutical adjuvants and is characterized in that the pharmaceutical adjuvants include an excipient and an adhesive; the weight percentages of the propolis, excipient and adhesive in the pellet preparation are respectively 5-20%, 70-85% and 1-5%. The pellet preparation has high dissolution rate and bioavailability. A preparation method is simple and convenient and is easy to operate.

The invention provides a lemon peel extract pellet preparation. The lemon peel extract pellet preparation is prepared from lemon peel extract and pharmaceutical adjuvant and is characterized in that the pharmaceutical adjuvant is composed of an excipient and an adhesive and the weight percentages of the lemon peel extract, the excipient and the adhesive are 10 to 30%, 65 to 85% and 1 to 5%, respectively. The pellet preparation provided by the invention has a high dissolution rate and high bioavailability; and the preparation method for the pellet preparation is simple, convenient and easily practicable.